This Viewpoint addresses the challenges that the Centers for Medicare and Medicaid Services faces to collect real-world data on the effectiveness and safety of lecanemab from external registries to achieve its coverage with evidence development objectives.
No takes yet. Share an insight, caveat, or question.
Socal et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: